Nonpartisan civic infrastructure
AllCiv·Legis1
·

S. 2817

BillFederalSenateIn Committee
A bill to require the Secretary of Health and Human Services to establish an annual reference price for insulin products for purposes of Federal health programs, and for other purposes.
About This Bill
Committee
Latest Action · November 7, 2019
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S6479-6480)
Congress
116th (2019–2021)
Introduced
November 7, 2019
Cosponsors (1)
1D 0R
View PDF ↗

Summary

Highlight any text to annotate
End Price Gouging for Insulin Act This bill requires the Department of Health and Human Services to set a maximum price for insulin products for individuals and enrollees of federal health programs.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.